Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

10x Genomics (TXG) Debt to Equity (2018 - 2019)

Historic Debt to Equity for 10x Genomics (TXG) over the last 2 years, with Q4 2019 value amounting to $0.07.

  • 10x Genomics' Debt to Equity rose 15244.34% to $0.07 in Q4 2019 from the same period last year, while for Dec 2019 it was $0.07, marking a year-over-year increase of 15244.34%. This contributed to the annual value of $0.07 for FY2019, which is 15244.34% up from last year.
  • Latest data reveals that 10x Genomics reported Debt to Equity of $0.07 as of Q4 2019, which was up 15244.34% from $0.07 recorded in Q3 2019.
  • Over the past 5 years, 10x Genomics' Debt to Equity peaked at $0.07 during Q4 2019, and registered a low of -$0.13 during Q4 2018.